MRNA logo

Moderna (MRNA) Working Capital

Annual Working Capital

$7.31 B
-$1.20 B-14.08%

31 December 2023

MRNA Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$7.46 B
+$167.00 M+2.29%

30 September 2024

MRNA Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRNA Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-14.1%+16.4%
3 y3 years+282.9%+115.3%
5 y5 years+445.4%+688.6%

MRNA Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-14.1%+282.9%-13.4%+115.3%
5 y5 years-14.1%+641.6%-13.4%+688.6%
alltimeall time-14.1%>+9999.0%-13.4%>+9999.0%

Moderna Working Capital History

DateAnnualQuarterly
Sept 2024
-
$7.46 B(+2.3%)
June 2024
-
$7.30 B(+1.1%)
Mar 2024
-
$7.22 B(-1.2%)
Dec 2023
$7.31 B(-14.1%)
$7.31 B(+14.0%)
Sept 2023
-
$6.41 B(-14.2%)
June 2023
-
$7.48 B(-13.3%)
Mar 2023
-
$8.62 B(+1.4%)
Dec 2022
$8.51 B(+22.5%)
$8.51 B(+13.6%)
Sept 2022
-
$7.49 B(+10.9%)
June 2022
-
$6.75 B(-5.1%)
Mar 2022
-
$7.11 B(+2.4%)
Dec 2021
$6.94 B(+263.7%)
$6.94 B(+100.2%)
Sept 2021
-
$3.47 B(+62.9%)
June 2021
-
$2.13 B(-34.7%)
Mar 2021
-
$3.26 B(+70.9%)
Dec 2020
$1.91 B(+93.7%)
$1.91 B(-9.3%)
Sept 2020
-
$2.10 B(-20.2%)
June 2020
-
$2.64 B(+136.3%)
Mar 2020
-
$1.12 B(+13.2%)
Dec 2019
$985.69 M(-26.5%)
$985.69 M(+4.1%)
Sept 2019
-
$946.62 M(+1.2%)
June 2019
-
$935.43 M(-4.7%)
Mar 2019
-
$981.67 M(-26.8%)
Dec 2018
$1.34 B(+126.5%)
$1.34 B(+43.9%)
Sept 2018
-
$931.53 M(+57.4%)
Dec 2017
$591.76 M(-36.0%)
$591.76 M(<-9900.0%)
Sept 2017
-
-$4.55 M(+21.2%)
June 2017
-
-$3.76 M(+63.5%)
Mar 2017
-
-$2.30 M(-13.3%)
Dec 2016
$924.35 M(<-9900.0%)
-
Dec 2016
-
-$2.65 M(-6.3%)
Sept 2016
-
-$2.83 M(+6.3%)
June 2016
-
-$2.66 M(+10.1%)
Mar 2016
-
-$2.42 M(+52.3%)
Dec 2015
-$1.59 M(-376.3%)
-$1.59 M(+42.1%)
Sept 2015
-
-$1.12 M(-15.0%)
June 2015
-
-$1.31 M(+136.6%)
Mar 2015
-
-$555.00 K(-196.7%)
Dec 2014
$574.00 K(-111.1%)
$574.00 K(-41.3%)
Sept 2014
-
$978.00 K(-58.9%)
June 2014
-
$2.38 M(-19.5%)
Mar 2014
-
$2.95 M(-157.1%)
Dec 2013
-$5.17 M(+5.7%)
-$5.17 M(-2.9%)
Sept 2013
-
-$5.33 M(-1.8%)
June 2013
-
-$5.42 M(+3.7%)
Mar 2013
-
-$5.23 M(+6.9%)
Dec 2012
-$4.89 M(+137.3%)
-$4.89 M(+15.8%)
Sept 2012
-
-$4.23 M(-12.2%)
June 2012
-
-$4.82 M(+30.4%)
Mar 2012
-
-$3.69 M(+79.0%)
Dec 2011
-$2.06 M(-37.7%)
-$2.06 M(+27.7%)
Sept 2011
-
-$1.62 M(+240.2%)
June 2011
-
-$475.00 K(-85.7%)
Mar 2011
-
-$3.31 M(+0.0%)
Dec 2010
-$3.31 M(+34.0%)
-$3.31 M(+34.0%)
Sept 2010
-
-$2.47 M(-55.8%)
June 2010
-
-$5.60 M(+476.9%)
Mar 2010
-
-$970.00 K(-60.8%)
Dec 2009
-$2.47 M(-67.3%)
-$2.47 M(-304.4%)
Sept 2009
-
$1.21 M(-81.1%)
June 2009
-
$6.39 M(+256.4%)
Mar 2009
-
$1.79 M(-123.7%)
DateAnnualQuarterly
Dec 2008
-$7.57 M(-124.3%)
-$7.57 M(-600.7%)
Sept 2008
-
$1.51 M(-87.2%)
June 2008
-
$11.85 M(-25.4%)
Mar 2008
-
$15.88 M(-49.0%)
Dec 2007
$31.11 M(-27.4%)
$31.11 M(-28.9%)
Sept 2007
-
$43.78 M(-24.9%)
June 2007
-
$58.32 M(-19.6%)
Mar 2007
-
$72.53 M(+69.3%)
Dec 2006
$42.83 M(-22.4%)
$42.83 M(-12.4%)
Sept 2006
-
$48.90 M(-13.1%)
June 2006
-
$56.30 M(-2.4%)
Mar 2006
-
$57.69 M(+4.5%)
Dec 2005
$55.20 M(-5.4%)
$55.20 M(-9.7%)
Sept 2005
-
$61.13 M(+38.2%)
June 2005
-
$44.22 M(-11.4%)
Mar 2005
-
$49.91 M(-14.5%)
Dec 2004
$58.36 M(+295.2%)
$58.36 M(+472.7%)
Sept 2004
-
$10.19 M(-25.9%)
June 2004
-
$13.76 M(+86.2%)
Mar 2004
-
$7.39 M(-50.0%)
Dec 2003
$14.77 M(+341.8%)
$14.77 M(-27.3%)
Sept 2003
-
$20.31 M(+32.2%)
June 2003
-
$15.36 M(+243.1%)
Mar 2003
-
$4.48 M(+34.0%)
Dec 2002
$3.34 M(-67.9%)
$3.34 M(-46.8%)
Sept 2002
-
$6.28 M(-59.1%)
June 2002
-
$15.37 M(-1.2%)
Mar 2002
-
$15.56 M(+49.5%)
Dec 2001
$10.40 M(+79.4%)
$10.40 M(+63.2%)
Sept 2001
-
$6.38 M(-5.3%)
June 2001
-
$6.73 M(-13.7%)
Mar 2001
-
$7.80 M(+34.5%)
Dec 2000
$5.80 M(-55.0%)
$5.80 M(-16.5%)
Sept 2000
-
$6.95 M(-16.8%)
June 2000
-
$8.35 M(-20.8%)
Mar 2000
-
$10.54 M(-18.3%)
Dec 1999
$12.90 M(-47.3%)
$12.90 M(-24.1%)
Sept 1999
-
$17.00 M(-16.3%)
June 1999
-
$20.30 M(-8.1%)
Mar 1999
-
$22.10 M(-9.8%)
Dec 1998
$24.50 M(+1.2%)
$24.50 M(-4.3%)
Sept 1998
-
$25.60 M(-1.2%)
June 1998
-
$25.90 M(+5.7%)
Mar 1998
-
$24.50 M(+1.2%)
Dec 1997
$24.20 M(+114.2%)
$24.20 M(-6.9%)
Sept 1997
-
$26.00 M(-4.8%)
June 1997
-
$27.30 M(-3.5%)
Mar 1997
-
$28.30 M(+277.3%)
Dec 1996
$11.30 M(+52.7%)
-
Sept 1996
-
$7.50 M(+1.4%)
June 1996
$7.40 M(0.0%)
$7.40 M(+76.2%)
Mar 1996
-
$4.20 M(+2.4%)
Dec 1995
-
$4.10 M(-4.7%)
Sept 1995
-
$4.30 M(-41.9%)
June 1995
$7.40 M(+57.4%)
$7.40 M(+60.9%)
Mar 1995
-
$4.60 M(-2.1%)
Dec 1994
-
$4.70 M(+2.2%)
Sept 1994
-
$4.60 M(-2.1%)
June 1994
$4.70 M
$4.70 M(0.0%)
Mar 1994
-
$4.70 M(0.0%)
Dec 1993
-
$4.70 M(-4800.0%)
Sept 1993
-
-$100.00 K

FAQ

  • What is Moderna annual working capital?
  • What is the all time high annual working capital for Moderna?
  • What is Moderna annual working capital year-on-year change?
  • What is Moderna quarterly working capital?
  • What is the all time high quarterly working capital for Moderna?
  • What is Moderna quarterly working capital year-on-year change?

What is Moderna annual working capital?

The current annual working capital of MRNA is $7.31 B

What is the all time high annual working capital for Moderna?

Moderna all-time high annual working capital is $8.51 B

What is Moderna annual working capital year-on-year change?

Over the past year, MRNA annual working capital has changed by -$1.20 B (-14.08%)

What is Moderna quarterly working capital?

The current quarterly working capital of MRNA is $7.46 B

What is the all time high quarterly working capital for Moderna?

Moderna all-time high quarterly working capital is $8.62 B

What is Moderna quarterly working capital year-on-year change?

Over the past year, MRNA quarterly working capital has changed by +$1.05 B (+16.39%)